<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: We tested the hypothesis that administration of the competitive <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> NPC 17742 (2R,4R,5S-[2-amino-4,5-(1,2-<z:chebi fb="0" ids="52552">cyclohexyl</z:chebi>)-7-phosphonoheptanoic acid]) during transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> affects early postischemic brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:chebi fb="2" ids="5615">Halothane</z:chebi>-anesthetized cats underwent 1 hour of left middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> plus 4 hours of reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>Control cats received saline (n = 7) </plain></SENT>
<SENT sid="3" pm="."><plain>Experimental cats were treated with NPC 17742 at a dose of 5 mg/kg IV from 45 minutes of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> to 15 minutes of reperfusion and 2.5 mg/kg per hour for 4 hours of reperfusion (NPC-5; n = 7) or 50 mg/kg from 45 minutes of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> to 15 minutes of reperfusion and 25 mg/kg per hour for 4 hours of reperfusion (NPC-50; n = 5) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Microsphere-determined blood flow to the ipsilateral inferior temporal cortex and caudate nucleus decreased to the same extent during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and recovered to the same extent during reperfusion in the three groups </plain></SENT>
<SENT sid="5" pm="."><plain>Triphenyltetrazolium-determined injury volume of ipsilateral cerebral hemisphere (saline, 24 +/- 8%; NPC-5, 4 +/- 2%; NPC-50, 5 +/- 2% of hemisphere; mean +/- SE) and caudate nucleus (saline, 72 +/- 6%; NPC-5, 37 +/- 10%; NPC-50, 26 +/- 4%) was less in cats treated with both doses of drug compared with cats treated with saline </plain></SENT>
<SENT sid="6" pm="."><plain>Recovery of somatosensory evoked potential amplitude was incomplete and similar in <z:hpo ids='HP_0000001'>all</z:hpo> groups (saline, 36 +/- 14%; NPC-5, 58 +/- 8%; NPC-50, 51 +/- 15% of baseline) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These data indicate that activation of <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors plays an important role in the mechanism of <z:hpo ids='HP_0011009'>acute</z:hpo> injury in both cortex and caudate after 1 hour of transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the cat </plain></SENT>
<SENT sid="8" pm="."><plain>Because NPC 17742 afforded protection when administered at the end of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and during reperfusion, <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor activation during reperfusion may contribute to the progression of injury in ischemic border regions </plain></SENT>
</text></document>